Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Assets: 2010-2025

Historic Current Assets for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to $28.0 million.

  • Sunshine Biopharma's Current Assets rose 7.64% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 7.64%. This contributed to the annual value of $26.0 million for FY2024, which is 4.32% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Current Assets stood at $28.0 million, which was up 0.42% from $27.9 million recorded in Q2 2025.
  • Sunshine Biopharma's Current Assets' 5-year high stood at $42.0 million during Q2 2022, with a 5-year trough of $1.8 million in Q2 2021.
  • Its 3-year average for Current Assets is $26.2 million, with a median of $26.0 million in 2024.
  • As far as peak fluctuations go, Sunshine Biopharma's Current Assets surged by 5,313.51% in 2021, and later tumbled by 37.84% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Current Assets (Quarterly) stood at $2.2 million in 2021, then surged by 1,143.83% to $27.3 million in 2022, then decreased by 8.87% to $24.9 million in 2023, then rose by 4.32% to $26.0 million in 2024, then grew by 7.64% to $28.0 million in 2025.
  • Its Current Assets was $28.0 million in Q3 2025, compared to $27.9 million in Q2 2025 and $24.5 million in Q1 2025.